The 2019 conference, led by Drs. Elizabeth M. Jaffee and Hong Wu, will feature a mix of topics that focus on specific cancers as well as emerging areas of research with applications across disease types. Sessions will cover drug development, epigenetics, genomics, immunotherapy, metabolism, and prevention as well as dedicated sessions on GI, liver, lung, nasopharyngeal, and gender-specific cancers.